Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $103.6500 (1.22%) ($101.0000 - $105.9900) on Thu. Aug. 25, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.2% (three month average) | RSI | 15 | Latest Price | $103.6500(1.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.7% a day on average for past five trading days. | Weekly Trend | LGND declines -5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(52%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.1% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) IPO(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.1% (StdDev 2.2%) | Hourly BBV | 0 () | Intraday Trend | 2.2% | | | |
|
1 - 5 Day Possible Target | $92.01(-11.23%) | Resistance Level | $116.23 | 5 Day Moving Average | $105.48(-1.73%) | 10 Day Moving Average | $107.98(-4.01%) | 20 Day Moving Average | $116.23(-10.82%) | To recent high | -25.2% | To recent low | 1.2% | Market Cap | $1.666b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |